The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.


Journal

Journal of neuropsychology
ISSN: 1748-6653
Titre abrégé: J Neuropsychol
Pays: England
ID NLM: 101468753

Informations de publication

Date de publication:
03 2019
Historique:
received: 29 03 2017
revised: 21 06 2017
pubmed: 18 7 2017
medline: 17 7 2020
entrez: 18 7 2017
Statut: ppublish

Résumé

Parkinson's disease (PD) is a neurological disorder associated primarily with motor symptoms such as tremor, slowness of movement, and difficulties with gait and balance. Most patients take dopaminergic medication to improve their motor functions. Previous studies reported indications that such medication can impair higher cognitive functions (cf. dopamine overdose hypothesis). In the present study, we examined the effect of medication status on conflict adaptation. PD patients performed a Stroop task in which we manipulated the proportion of congruent and incongruent items, thereby allowing us to explore conflict adaptation. The use of mouse movements allowed us to examine the action dynamics of conflict adaptation in PD, and their sensitivity to dopaminergic medication. Each patient performed the same task twice: once without making changes to their regular medication regime, and once after overnight withdrawal from their medication. Results showed that medication improved mouse movements and alleviated motor symptoms. Moreover, patients' mouse movements were modulated as a function of the proportion congruency manipulation, revealing conflict adaptation in PD, which was unaffected by medication status. The present study extends earlier work on conflict adaptation in PD where reduced transient (trial-by-trial) conflict adaptation was observed ON compared to OFF medication (Duthoo et al., 2013, Neuropsychology, 27, 556). Our findings suggest that more sustained cognitive control processes may not be sensitive to dopamine overdose effects.

Identifiants

pubmed: 28714199
doi: 10.1111/jnp.12131
doi:

Substances chimiques

Antiparkinson Agents 0
Dopamine Agents 0
Dopamine Agonists 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-135

Informations de copyright

© 2017 The British Psychological Society.

Auteurs

Marit F L Ruitenberg (MFL)

Department of Experimental Psychology, Faculty of Psychology and Educational Sciences, Ghent University, Belgium.

Elger L Abrahamse (EL)

Department of Experimental Psychology, Faculty of Psychology and Educational Sciences, Ghent University, Belgium.

Patrick Santens (P)

Department of Neurology, Ghent University Hospital, Belgium.

Wim Notebaert (W)

Department of Experimental Psychology, Faculty of Psychology and Educational Sciences, Ghent University, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH